Orgenesis Inc reports four-fold increase in revenue in 1Q as it continues to grow its POCare strategy

Orgenesis reports four-fold increase in revenue in 1Q as it continues to grow its POCare strategy
Revenue in the three months came in at $9.4 million, up from $1.8 million in the first quarter of 2020
It identifies promising new therapies and leverages its POCare Platform to provide a pathway for them to reach and treat large numbers of patients at lowered costs
Orgenesis Inc (NASDAQ:ORGS) (FRA:45O), the cell and gene therapies (CGTs) focused biotech, reported a four-fold increase in revenue in its first quarter to end-March, as the company continues its journey to build a long-term profitable business with its Point of Care (POCare) strategy.  

Related Keywords

United States ,America ,Vered Caplan ,Pocare Network ,North America ,ஒன்றுபட்டது மாநிலங்களில் ,அமெரிக்கா ,வடக்கு அமெரிக்கா ,